Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy ; volume:17 ; number:1 ; day:23 ; month:6 ; year:2017 ; pages:1-10 ; date:12.2017
BMC urology ; 17, Heft 1 (23.6.2017), 1-10, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Yashi, Masahiro
- Contributor
-
Nukui, Akinori
Tokura, Yuumi
Takei, Kohei
Suzuki, Issei
Sakamoto, Kazumasa
Yuki, Hideo
Kambara, Tsunehito
Betsunoh, Hironori
Abe, Hideyuki
Fukabori, Yoshitatsu
Nakazato, Yoshimasa
Kaji, Yasushi
Kamai, Takao
SpringerLink (Online service)
- DOI
-
10.1186/s12894-017-0238-y
- URN
-
urn:nbn:de:1111-201709139178
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yashi, Masahiro
- Nukui, Akinori
- Tokura, Yuumi
- Takei, Kohei
- Suzuki, Issei
- Sakamoto, Kazumasa
- Yuki, Hideo
- Kambara, Tsunehito
- Betsunoh, Hironori
- Abe, Hideyuki
- Fukabori, Yoshitatsu
- Nakazato, Yoshimasa
- Kaji, Yasushi
- Kamai, Takao
- SpringerLink (Online service)
Other Objects (12)
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen